Helicobacter pylori-Induced Progranulin Promotes the Progression of the Gastric Epithelial Cell Cycle by Regulating CDK4

키워드

참고문헌 (76)

1. Ford AC, "Helicobacter pylori eradication therapy to prevent gastric cancer : systematic review and metaanalysis", Gut, 69, pp.2113~2121 (2020)
2. Sung H, "Global Cancer Statistics 2020 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J. Clin, 71, pp.209~249 (2021)
3. Karimi P, "Gastric cancer : descriptive epidemiology, risk factors, screening, and prevention", Cancer Epidemiol. Biomarkers Prev, 23, pp.700~713 (2014)
4. Zheyu Song, "Progress in the treatment of advanced gastric cancer", Tumor Biology, 39(7), pp.101042831771462~ (2017), IOS Press[DOI]
5. Schistosomes, "IARC Working Group on the Evaluation of Carcinogenic Risks to Humans", IARC Monogr. Eval. Carcinog. Risks Hum, 61, pp.7~14 (1994)
6. Gonzalez CA, "Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study : the Eurgast-EPIC project", Ann. Oncol, 23, pp.1320~1324 (2012)
7. Hooi JKY, "Global prevalence of Helicobacter pylori infection : Systematic review and meta-analysis", Gastroenterology, 153, pp.420~429 (2017)
8. Jaehoon Cho, "Helicobacter pylori Infection", Gastroenterology Clinics of North America, 50(2), pp.261~282 (2021), Elsevier BV[DOI]
9. Wang F, "Helicobacter pylori-induced gastric inflammation and gastric cancer", Cancer Lett, 345, pp.196~202 (2014)
10. Hochegger H, "Cyclin-dependent kinases and cell-cycle transitions : does one fit all?", Nat. Rev. Mol. Cell Biol, 9, pp.910~916 (2008)
11. Enders GH, "Mammalian interphase cdks : dispensable master regulators of the cell cycle", Genes Cancer, 3, pp.614~618 (2012)
12. Gao X, "Cyclin D-CDK4", 6 functions in cancer, 2020, pp.148, 147~169
13. Tadesse S, "Cyclin-eependent kinase 2 inhibitors in cancer therapy : An update", J. Med. Chem, 62, pp.4233~4251 (2019)
14. Kastan MB, "Cell-cycle checkpoints and cancer", Nature, 432, pp.316~323 (2004)
15. Heide L. Ford, "Cancer and the cell cycle", Journal of Cellular Biochemistry, 75(S32), pp.166~172 (1999), Wiley[DOI]
16. Sherr CJ, "Cancer cell cycles", Science, 274, pp.1672~1677 (1996)
17. Fong LY, "Early deregulation of the the p16ink4a-cyclin D1", cyclin-dependent kinase 4-retinoblastoma pathway in cell proliferation-driven esophageal tumorigenesis in zinc-deficient rats, 2000, pp.60, 4589~4595
18. Guha R, "Anti-progranulin", GP88 antibody AG01 inhibits triple negative breast cancer cell proliferation and migration, 2021, pp.186, 637~653
19. Zhao J, "Effect of progranulin on migration and invasion of human colon cancer cells", J. Coll. Physicians Surg. Pak, 28, pp.607~611 (2018)
20. Walsh CE, "Progranulin regulates neurogenesis in the developing vertebrate retina", Dev. Neurobiol, 77, pp.1114~1129 (2017)
21. He Z, "Progranulin is a mediator of the wound response", Nat. Med, 9, pp.225~229 (2003)
22. Wei J, "Progranulin promotes diabetic fracture healing in mice with type 1diabetes", Ann. NY Acad. Sci, 1460, pp.43~56 (2020)
23. Xu B, "Abnormal angiogenesis of placenta in progranulindeficient mice", Mol. Med. Rep, 22, pp.3482~3492 (2020)
24. Lu J, "Progranulin ameliorates lung inflammation in an LPS-induced acute lung injury mouse model by modulating macrophage polarization and the MAPK pathway", Ann. Clin. Lab. Sci, 51, pp.220~230 (2021)
25. Li H, "PGRN exerts inflammatory effects via SIRT1-NF-kappaB in adipose insulin resistance", J. Mol. Endocrinol, 64, pp.181~193 (2020)
26. Feng JQ, "Granulin epithelin precursor : a bone morphogenic protein 2-inducible growth factor that activates Erk1", 2 signaling and JunB transcription factor in chondrogenesis, 2010, pp.24, 1879~1892
27. Abdulrahman A, "Expression of GP88(Progranulin)protein is an independent prognostic factor in prostate cancer patients", Cancers(Basel), 11, pp.2029~ (2019)
28. Feng T, "Growth factor progranulin promotes tumorigenesis of cervical cancer via PI3K", Akt, Oncotarget, pp.2016, 7[DOI]
29. Kimura A, "Higher levels of progranulin in cerebrospinal fluid of patients with lymphoma and carcinoma with CNS metastasis", J. Neurooncol, 137, pp.455~462 (2018)
30. Yang D, "Progranulin promotes colorectal cancer proliferation and angiogenesis through TNFR2", Akt and ERK signaling pathways, 2015, pp.5, 3085~3097
31. Buraschi S, "Progranulin", EphA2 axis : A novel oncogenic mechanism in bladder cancer, 2020, pp.93, 10~24
32. Yabe K, "Progranulin depletion inhibits proliferation via the transforming growth factor beta", SMAD family member 2 signaling axis in Kasumi-1 cells, 2021, pp.7, e05849~
33. Fang W, "Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages(TAMs)and promoting CD8(+)T cell exclusion", J. Exp. Clin. Cancer Res, 40, pp.4~ (2021)
34. Zhou C, "A narrative review of multiple mechanisms of progranulin in cancer : a potential target for anti-cancer therapy", Transl. Cancer Res, 10, pp.4207~4216 (2021)
35. Liu B, "HP-CagA+ regulates the expression of CDK4", CyclinD1 via reg3 to change cell cycle and promote cell proliferation, 2019, pp.21, 224~
36. Wang H, "Upregulation of progranulin by Helicobacter pylori in human gastric epithelial cells via p38MAPK and MEK1", 2 signaling pathway : role in epithelial cell proliferation and migration, 2011, pp.63, 82~92
37. Livak KJ, "Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T))method", Methods, 25, pp.402~408 (2001)
38. Tang W, "The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice", Science, 332, pp.478~484 (2011)
39. Arechavaleta-Velasco F, "Progranulin and its biological effects in cancer", Med. Oncol, 34, pp.194~ (2017)
40. Jian J, "Progranulin : A key player in autoimmune diseases", Cytokine, 101, pp.48~55 (2018)
41. Demorrow S, "Progranulin : a novel regulator of gastrointestinal cancer progression", Transl. Gastrointest. Cancer, 2, pp.145~151 (2013)
42. Dong T, "PGRN promotes migration and invasion of epithelial ovarian cancer cells through an epithelial mesenchymal transition program and the activation of cancer associated fibroblasts", Exp. Mol. Pathol, 100, pp.17~25 (2016)
43. Klupp F, "Granulin : an invasive and survival-determining marker in colorectal cancer patients", Int. J. Mol. Sci, 22, pp.6436~ (2021)
44. Wang W, "PC cell-derived growth factor(granulin precursor)expression and action in human multiple myeloma", Clin. Cancer Res, 9, pp.2221~2228 (2003)
45. Lu R, "Inhibition of PC cell-derived growth factor(PCDGF, epithelin", granulin precursor)expression by antisense PCDGF cDNA transfection inhibits tumorigenicity of the human breast carcinoma cell line MDA-MB-468, 2000, pp.97, 3993~3998
46. Serrero G, "Progranulin(GP88)tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma", Breast Cancer Res, 14, pp.R26~ (2012)
47. Ho JC, "Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma", Hepatology, 47, pp.1524~1532 (2008)
48. Wu JY, "The eradication of Helicobacter pylori to prevent gastric cancer : a critical appraisal", Expert Rev. Gastroenterol. Hepatol, 13, pp.17~24 (2019)
49. Zhou Z, "Expression of Wnt3, beta-catenin and MMP-7 in gastric cancer and precancerous lesions and their correlations with Helicobacter pylori infection", Zhong Nan Da Xue Xue Bao Yi Xue Ban, 46, pp.575~582 (2021)
50. Molaei F, "Molecular signaling in tumorigenesis of gastric cancer", Iran Biomed. J, 22, pp.217~230 (2018)
51. Padda J, "Association between Helicobacter pylori and gastric carcinoma", Cureus, 13, pp.e15165~ (2021)
52. Kato MV, "Up-regulation of cell cycle-associated genes by p53 in apoptosis of an erythroleukemic cell line", Leukemia, 11(3), pp.389~392 (1997)
53. Woodward TA, "Barrett's esophagus, apoptosis and cell cycle regulation : correlation of p53with Bax, Bcl-2 and p21 protein expression", Anticancer Res, 20, pp.2427~2432 (2000)
54. Chinzei N, "P21 deficiency delays regeneration of skeletal muscular tissue", PLoS One, 10, pp.e0125765~ (2015)
55. Megraud F, "Helicobacter pylori infection and gastric carcinoma", Clin. Microbiol. Infect, 21, pp.984~990 (2015)
56. Evan GI, "Proliferation, cell cycle and apoptosis in cancer", Nature, 411, pp.342~348 (2001)
57. Kar S, "Unraveling cell-cycle dynamics in cancer", Cell Syst, 2, pp.8~10 (2016)
58. Pack LR, "Putting the brakes on the cell cycle : mechanisms of cellular growth arrest", Curr. Opin. Cell Biol, 60, pp.106~113 (2019)
59. Campbell GJ, "The role of CDKs and CDKIs in murine development", Int. J. Mol. Sci, 21, pp.5343~ (2020)
60. Canepa ET, "INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions", IUBMB Life, 59, pp.419~426 (2007)
61. Jackson RJ, "Loss of the cell cycle inhibitors p21(Cip1)and p27(Kip1)enhances tumorigenesis in knockout mouse models", Oncogene, 21, pp.8486~8497 (2002)
62. Ahmed A, "Helicobacter pylori inhibits gastric cell cycle progression", Microbes Infect, 2, pp.1159~1169 (2000)
63. Nianshuang Li, "p53, a potential predictor of<i>Helicobacter pylori<", i>infection-associated gastric carcinogenesis?, 2016, pp.7(40), 66276~66286[DOI]
64. Sherr CJ, "D-type cyclins", Trends Biochem. Sci, 20, pp.187~190 (1995)
65. Shirin H, "Helicobacter pylori inhibits the G1 to S transition in AGS gastric epithelial cells", Cancer Res, 59, pp.2277~2281 (1999)
66. Scotti C, "Cell-cycle inhibition by Helicobacter pylori Lasparaginase", PLoS One, 5, pp.e13892~ (2010)
67. Cover TL, "Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin", Cancer Res, 63, pp.951~957 (2003)
68. Kyung-Mi Kim, "Helicobacter pylori γ-Glutamyltranspeptidase Induces Cell Cycle Arrest at the G1-S Phase Transition", The Journal of Microbiology, 48(3), pp.372~377 (2010), 한국미생물학회
69. Huanying Li, "Helicobacter pylori inhibited cell proliferation in human periodontal ligament fibroblasts through the Cdc25C", CDK1, Journal of Periodontal & Implant Science, pp.2019, 49(3)[DOI]
70. Carolina Alquezar, "Alteration in cell cycle-related proteins in lymphoblasts from carriers of the c.709-1G&gt;A PGRN mutation associated with FTLD-TDP dementia", Neurobiology of Aging, 33(2), pp.429.e7~429.e20 (2012), Elsevier BV[DOI]
71. Alquezar C, "PGRN haploinsufficiency increased Wnt5a signaling in peripheral cells from frontotemporal lobar degeneration-progranulin mutation carriers", Neurobiol. Aging, 35, pp.886~898 (2014)
72. Teo ZL, "Combined CDK4", 6 and PI3Kalpha inhibition is synergistic and immunogenic in triple-negative breast cancer, 2017, pp.77, 6340~6352
73. Kollmann K, "The interplay of CDK4 and CDK6 in melanoma", Oncotarget, 10, pp.1346~1359 (2019)
74. Lu Y, "Growth factor progranulin contributes to cervical cancer cell proliferation and transformation in vivo and in vitro", Gynecol. Oncol, 134, pp.364~371 (2014)
75. He Z, "Progranulin(PC-cell-derived growth factor", acrogranin)regulates invasion and cell survival, 2002, pp.62, 5590~5596
76. Richard M. Peek, "Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in Mongolian gerbils", Gastroenterology, 118(1), pp.48~59 (2000), Elsevier BV[DOI]

관련 논문AI추천